Iasevoli, Felice

Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a

Serchov, T., Clement, H.-W., Schwarz, M. K., Iasevoli, F., Tosh, D. K., Idzko, M., Jacobson, K. A., de Bartolomeis, A., Normann, C., Biber, K., et al. (2015) · Neuron

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 210

An update of safety of clinically used atypical antipsychotics

Orsolini, L., Tomasetti, C., Valchera, A., Vecchiotti, R., Matarazzo, I., Vellante, F., Iasevoli, F., Buonaguro, E. F., Fornaro, M., Fiengo, A. L. C., et al. (2016) · Expert Opinion on Drug Safety

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 135

Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: translational relevance for schizophrenia and antipsychotic treatment: a systematic review

de Bartolomeis, A., Barone, A., Vellucci, L., Mazza, B., Austin, M. C., Iasevoli, F., & Ciccarelli, M. (2022) · Molecular Neurobiology

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 113

The relationship between emotional regulation and eating behaviour: A multidimensional analysis of obesity psychopathology

Micanti, F., Iasevoli, F., Cucciniello, C., Costabile, R., Loiarro, G., Pecoraro, G., Pasanisi, F., Rossetti, G., & Galletta, D. (2017) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 107

Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

de Bartolomeis, A., Buonaguro, E. F., & Iasevoli, F. (2013) · Psychopharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 89

The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis

Fornaro, M., Carvalho, A. F., De Prisco, M., Mondin, A. M., Billeci, M., Selby, P., Iasevoli, F., Berk, M., Castle, D. J., & de Bartolomeis, A. (2022) · Neuroscience & Biobehavioral Reviews

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 82

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis

de Bartolomeis, A., Sarappa, C., Buonaguro, E. F., Marmo, F., Eramo, A., Tomasetti, C., & Iasevoli, F. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 72

Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes

de Bartolomeis, A., Buonaguro, E. F., Latte, G., Rossi, R., Marmo, F., Iasevoli, F., & Tomasetti, C. (2017) · Frontiers in Behavioral Neuroscience

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 44

Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis

Iasevoli, F., Polese, D., Ambesi-Impiombato, A., Muscettola, G., & de Bartolomeis, A. (2007) · Neuroscience Letters

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 40

Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole

Berardis, D., Fornaro, M., Serroni, N., Marini, S., Piersanti, M., Cavuto, M., Valchera, A., Mazza, M., Girinelli, G., Iasevoli, F., et al. (2014) · Recent Patents on Endocrine, Metabolic & Immune Drug Discovery

Schizophrenia research and treatmentPituitary Gland Disorders and Treatments

Cited by 24

MicroRNAs in schizophrenia: implications for synaptic plasticity and dopamine–glutamate interaction at the postsynaptic density. New avenues for antipsychotic treatment under a theranostic perspective

de Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology

Schizophrenia research and treatmentMicroRNA in disease regulation

Cited by 21